We are live on ! Find out more
PHVS icon

Pharvaris
PHVS

106 hedge funds and large institutions have $1.64B invested in Pharvaris in 2025 Q4 according to their latest regulatory filings, with 31 funds opening new positions, 42 increasing their positions, 15 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed

417% more first-time investments, than exits

New positions opened: 31 | Existing positions closed: 6

180% more repeat investments, than reductions

Existing positions increased: 42 | Existing positions reduced: 15

50% more funds holding in top 10

Funds holding in top 10: 8 → 12 (+4)

28% more funds holding

Funds holding: 83 → 106 (+23)

14% more capital invested

Capital invested by funds: $1.44B → $1.64B (+$195M)

100% less call options, than puts

Call options by funds: $0 | Put options by funds: $2.02M

Holders
106
Holders Change
+23
Holders Change %
+27.71%
% of All Funds
1.29%
Holding in Top 10
12
Holding in Top 10 Change
+4
Holding in Top 10 Change %
+50%
% of All Funds
0.15%
New
31
Increased
42
Reduced
15
Closed
6
Calls
–
Puts
$2.02M
Net Calls
-$2.02M
Net Calls Change
-$2.02M

Top Buyers

Rank Fund Capital Flow
1
DM
Deerfield Management
New York
+$16.5M
2
EP
Eversept Partners
New York
+$10.6M
3
BlackRock
BlackRock
New York
+$7.08M
4
IC
Ikarian Capital
Texas
+$6.66M
5
SVCM
Saturn V Capital Management
Texas
+$6.11M

Top Sellers

Rank Fund Capital Flow
1
PBA
Paradigm Biocapital Advisors
New York
-$45.8M
2
VA
VR Adviser
New York
-$16.8M
3
CC
Commodore Capital
New York
-$12.7M
4
BCLSI
Bain Capital Life Sciences Investors
Massachusetts
-$9.13M
5
CAM
Cormorant Asset Management
Massachusetts
-$6.75M
Name Holding Trade Value Shares
Change 		Change in
Stake
EC
26
Elmind Capital
New York
$13.2M +$11.5M +475,750 New
EP
27
Eversept Partners
New York
$12.2M +$10.6M +439,177 New
BBA
28
Baker Bros. Advisors
New York
$10.4M – – –
D.E. Shaw & Co
29
D.E. Shaw & Co
New York
$7.23M +$5.72M +237,686 +1,039%
Millennium Management
30
Millennium Management
New York
$6.91M +$3.43M +142,310 +134%
Morgan Stanley
31
Morgan Stanley
New York
$6.89M +$4.58M +190,071 +326%
PCH
32
Polar Capital Holdings
United Kingdom
$6.6M -$644K -26,731 -10%
Two Sigma Investments
33
Two Sigma Investments
New York
$5.97M +$4.93M +204,581 +1,929%
O
34
OrbiMed
New York
$5.7M +$4.95M +205,400 New
KCM
35
Kalehua Capital Management
Texas
$5.52M +$4.79M +198,772 New
TAM
36
TFG Asset Management
Cayman Islands
$5.4M – – –
HS
37
HighVista Strategies
Massachusetts
$4.51M +$3.91M +162,370 New
State Street
38
State Street
Massachusetts
$4.48M +$451K +18,724 +13%
Goldman Sachs
39
Goldman Sachs
New York
$4.47M +$3.53M +146,434 +1,012%
BFM
40
Boothbay Fund Management
New York
$4.36M +$528K +21,936 +16%
Schroder Investment Management Group
41
Schroder Investment Management Group
United Kingdom
$4.15M +$3.52M +145,946 +1,209%
UBS Group
42
UBS Group
Switzerland
$3.82M +$168K +6,982 +5%
Citadel Advisors
43
Citadel Advisors
Florida
$3.75M +$128K +5,331 +4%
Alyeska Investment Group
44
Alyeska Investment Group
Illinois
$3.47M – – –
TD Asset Management
45
TD Asset Management
Ontario, Canada
$3.34M +$383K +15,892 +15%
Squarepoint
46
Squarepoint
New York
$2.78M +$2.42M +100,359 New
LGM
47
Logos Global Management
California
$2.77M -$1.2M -50,000 -33%
Two Sigma Advisers
48
Two Sigma Advisers
New York
$2.49M +$2.16M +89,600 New
Geode Capital Management
49
Geode Capital Management
Massachusetts
$2.41M +$199K +8,261 +11%
ACM
50
ADAR1 Capital Management
Texas
$2.37M +$1.24M +51,404 +151%
1
2
3 4 5

PHVS Hedge Fund Activity: Q4 2025 in Review

106 of the 8,238 institutional investors tracked by Wall St. Rank reported a position in Pharvaris (PHVS) for Q4 2025, worth a combined $1.64B — up 14% from $1.44B a quarter earlier.

Buyers outnumbered sellers: 31 funds opened new PHVS positions and 6 closed out — a net gain of 25 holders — while 42 added to existing stakes and 15 trimmed.

The largest buyer was Deerfield Management, adding an estimated $16.5M. The largest seller was Paradigm Biocapital Advisors, exiting entirely with an estimated $45.8M sold.

  • 106 institutional investors held Pharvaris (PHVS) as of Q4 2025, up from 83 in Q3 2025.
  • Funds reported $1.64B of Pharvaris stock for Q4 2025, up 14% quarter-over-quarter.
  • 31 funds opened new Pharvaris positions in Q4 2025 and 6 closed out, a net change of +25 holders.
  • The largest Pharvaris buyer in Q4 2025 was Deerfield Management, an estimated $16.5M added.
  • The largest Pharvaris seller in Q4 2025 was Paradigm Biocapital Advisors, an estimated $45.8M sold.

Based on aggregated 13F filings for Q4 2025.